Fund Holdings — Stonepine Capital Management, LLC

Total Portfolio Value:
$231.23M
Total Bought:
$25.86M
Total Sold:
$96.36M
Net Transaction:
-$70.50M
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Evolus, Inc.(EOLS)5,179,0045,333,004+154,000$47.34M$56.16M24.29%+$8.82M
Adma Biologics Inc9,104,2759,222,617+118,342$32.59M$41.69M18.03%+$9.09M
Amylyx Pharmaceuticals, Inc.(AMLX)2,515,8682,500,000-15,868$46.07M$36.80M15.92%-$9.27M
QuidelOrtho Corporation(QDEL)658,794450,000-208,794$48.12M$33.16M14.34%-$14.95M
Alimera Sciences Inc3,983,6863,999,459+15,773$12.35M$17.28M7.47%+$4.93M
Xeris Biopharma Holdings Inc5,915,3725,937,000+21,628$11.00M$13.95M6.03%+$2.95M
Lakefront Biotherapeutics NVADR(LKFT)802,544261,870-540,674$27.73M$10.65M4.60%-$17.08M
Xoma Corp436,602250,000-186,602$6.15M$4.63M2.00%-$1.53M
Io Biotech Inc1,975,3081,666,037-309,271$2.79M$3.13M1.35%+$347.0K
SCYNEXIS, Inc.(SCYX)2,852,5991,355,186-1,497,413$6.50M$3.02M1.31%-$3.48M
Rezolute, Inc.(RZLT)3,072,4762,768,656-303,820$4.06M$2.75M1.19%-$1.31M
Atea Pharmaceuticals, Inc.(AVIR)1,720,000839,514-880,486$5.16M$2.56M1.11%-$2.60M
TELA Bio, Inc.(TELA)491,919317,782-174,137$3.94M$2.10M0.91%-$1.83M
Aytu Biopharma Inc472,369472,469+100$1.28M$1.34M0.58%+$66.4K
Exagen Inc.(XGN)1,203,491669,684-533,807$2.91M$1.33M0.58%-$1.58M
Atyr Pharma Inc4,626,624482,258-4,144,366$7.31M$680.0K0.29%-$6.63M
ASSERTIO HOLDINGS INCCOM NEW951,1970-951,197$2.44M$0—-$2.44M
DELCATH SYSTEMS INCCOM NEW(DCTH)686,2400-686,240$2.78M$0—-$2.78M
GAMIDA CELL LTDSHS7,965,8650-7,965,865$8.20M$0—-$8.20M
GOSSAMER BIO INCCOM(GOSS)3,339,4050-3,339,405$2.78M$0—-$2.78M
MAXCYTE INCCOM(MXCT)3,761,6400-3,761,640$11.74M$0—-$11.74M
VANDA PHARMACEUTICALS INCCOM(VNDA)477,9030-477,903$2.06M$0—-$2.06M
X4 PHARMACEUTICALS INCCOM(XFOR)5,273,6850-5,273,685$5.75M$0—-$5.75M
Page 1 of 1
Stonepine Capital Management, LLC — 13F Holdings — Q4 2023 | TickerTrail